Posted on 07/13/2023 4:24:30 AM PDT by RoosterRedux
Chip designer Nvidia (NVDA.O) will invest $50 million to speed up training of Recursion's (RXRX.O) artificial intelligence models for drug discovery, the companies said on Wednesday, sending the biotech firm's shares surging about 83%.
Recursion, whose advisers include AI pioneer Yoshua Bengio, will use its biological and chemical datasets exceeding 23,000 terabytes to train AI models on Nvidia's cloud platform.
Nvidia, seen as a big winner of the boom in artificial intelligence, could then license those models to biotech firms through BioNeMo, a generative AI cloud service for drug discovery that it rolled out earlier this year.
The company sold Nvidia over 7.7 million of its Class A common stock, which equates to an about 4% stake in the company.
The biopharma company runs the Recursion OS platform that gives drugmakers access to datasets required for designing and developing therapeutics.
The investment comes as Recursion strengthened its AI focus in May by snapping up two companies in the AI-driven drug discovery space for $87.5 million.
Recursion plans to use Nvidia's software to support its own pipeline, as well as its partners'. The Salt Lake City, Utah-based company's current partners include Bayer (BAYGn.DE) and Roche (ROG.S).
(Excerpt) Read more at reuters.com ...
Has AI decided what political figures that we need to get rid of first?
Right now it is only crunching data. Massive amounts of data.
I wonder what it thinks of the covid vax.
All of them. It won't want the competition.
But I think AI investing has reached a bubble phase and soon we'll realize it's like other fad investing. Definitely good for various use cases, but not worth the hype money currently invested in it now.
Meh. In my class, we could only code in 0s and 1s, and sometimes, we didn't even have the 1s.
Do you have experience analyzing stocks?
I mainly do mutual funds and ETF’s. When I move money around some, it’s largely from analyzing asset classes instead of individual companies. And even when I do that, it’s mainly broad trends more than situational factors. For example, I’m more liable to put more money into my energy fund because it’s below it’s 200 SMA than because Putin invaded Ukraine.
What kind of poison is AI going to inflict on us?
“…biological and chemical datasets exceeding 23,000 terabytes”
No kidding that is large!
With most brokerage firms (I use Schwab) having eliminated trade commissions, it is quite easy to create your own ETF. For example, I did this several years ago with QQQ. I went through the 100 companies included in QQQ and selected the stars (and eliminated the dogs)...and then created my own personal "QQQ."
My return has been significantly greater than QQQ. That said, my volatility is greater and that might make some investors nervous. Doesn't bother me because the higher return more than offsets any volatility.
Nvidia is clearly the leader in this area.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.